NCT02073019View on ClinicalTrials.gov

A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers

PHASE1CompletedINTERVENTIONAL

Enrollment

33

Participants

Timeline

Start Date

August 31, 2014

Primary Completion Date

July 31, 2015

Study Completion Date

July 31, 2015

Conditions

Mobilization of Hematopoietic Stem Cells (HSC) to Peripheral Blood (PB)

Interventions

DRUG

BL-8040

DRUG

Placebo

Trial Locations (1)

Unknown

Hadassah Clinical Research Center, Jerusalem

Sponsors

Lead Sponsor

BioLineRx, Ltd.

All Listed Sponsors

lead

BioLineRx, Ltd.

INDUSTRY

NCT02073019 - A Phase I Study Evaluating Safety, Tolerability, PK and PD of BL-8040 for Stem Cell Mobilization in Healthy Volunteers | Biotech Hunter | Biotech Hunter